The Food and Drug Administration () will be asked to approve MDMA for medical use by October, it has been revealed.
This will pave the way for the drug to be available in hospitals before the second half of next year for treating post-traumatic stress disorder (PTSD).
Scientists behind Meet Molly: The Truth About MDMA (Ecstasy or “Eâ€) research are confident they will get approval, saying there are unlikely to be any ‘tricky questions’ from regulators.
Also known as ecstasy and molly, the drug is popular in rave culture, where it is used to dance all night long and feel ‘more connected’ to music.
But it can also help people with Post-Traumatic Stress Disorder (PTSD), who suffer flashbacks and struggle to hold down work and maintain their personal lives.
Experts say the submission will pave the way for MDMA to be approved for use for PTSD patients before the second half of next year (stock image)
Patients take a standard dose of the drug while under supervision. They are also asked to wear a face mask and headphones.Sessions with a therapist then help people to come to terms with their trauma (image of trial provided by MAPS)
Nearly one in thirty-three Americans — or about eight million people — are suffering from PTSD, estimates show.
This has been triggered by experiences in conflict zones and serious accidents, leaving patients with intense, disturbing thoughts and feelings related to their experience.
At times, this can mean sufferers appear ‘vacant’ as they try to suppress a painful memory in their minds.
Medics currently try to treat the condition using harsh antidepressants which suppress the immune system and How To Order Magic Mushrooms Online cause a range of side effects and some talking therapies.
